RESERVIST aims to establish ‘reservist cells’ that in times of crises can be activated within 48hrs to switch to manufacturing medical products and services that are spiking in demand. Such a ‘reservist cell’ will consist of (i) a backbone network of core companies for manufacturing and testing; (ii) an extended network for further capacities (eg local provision, packaging, distribution, customization,…); (iii) a digital coordination platform and (iv) a pool of experts from the companies of the network. These cells will become operational in case of an emergency/pandemic but to make economic sense, the same approach of rapid flexibility and adaptability will be used to deal with surging demand in ‘normal circumstances’. To realise this concept, we will first work on three levels individually: network level, connected manufacturing/digital manufacturing level and technical level, the latter referring to tweaking manufacturing lines, developing required materials and establishing links with testing/certification. Next, we will demonstrate the repurposing of 5 existing manufacturing lines within 48hrs towards manufacturing of ‘textile PPE’ (surgical and respiratory face masks, medical aprons) and ‘respiratory ventilators’ (invasive and non invasive) that comply with necessary testing and certification and proceed with the embedment of the reservist cells at the partners in the network. We will develop blueprints for further take-up and replication of the concept to other sectors. Within the project we will develop two replication demos: ‘disinfection equipment’ and ‘emergency medical equipement’. To support the Cells we will tap into the worldwide maker community and into relevant OITBs and networks. The consortium is strongly industry-driven, including 4 LE and 7 SMEs coming from 7 EU countries. To maximise impact, we will extend our partner network and our Impact Support Group (18 Support Letters provided at proposal stage).

WEARPLEX is a multidisciplinary research and innovation action with the overall aim to integrate printed electronics with flexible and wearable textile-based biomedical multi-pad electrodes. It aims to answer the growing need for user-friendly electrodes for pervasive measurement of electrophysiological signals and application of electrical stimulation. It focuses on the development of the printable electronics and manufacturing processes for stretchable textile based multi-pad electrodes with integrated logic circuits that enable a significant increase in the number of electrode pads (channels) and facilitate the creation of new products in the sectors of medical electronics and life-style. The advanced printed electronics integrated in WEARPLEX electrodes will allow the individual pads to be connected in arbitrary configurations to the output leads of the electrode. Therefore, the pads will be flexibly organized into several virtual electrodes of arbitrary position, shape and size that can be connected to any standard multi-channel recording and stimulation system. In addition, software methods will be developed for automatic calibration of these virtual electrodes, to detect stimulation/recording hotspots and adjust the virtual electrodes accordingly. Therefore, the WEARPLEX project will lead to a new generation of smart electrodes that will be able to adapt simultaneously to the user (wearable and stretchable garment), recording/stimulation scenario (movement type and target muscles) and recording/stimulation system (number of channels). This is a paradigm shift in designing the recording and stimulation systems, as the switching electronics is shifted from the custom-made stimulator/recording device to the smart electrode, leading to a universal solution compatible with any system.

Intelligent Reliability 4.0 (iRel40) has the ultimate goal of improving reliability for electronic components and systems by reducing failure rates along the entire value chain. Trend for system integration, especially for heterogeneous integration, is miniaturization. Thus, reliability becomes an increasing challenge on device and system level and faces exceptional requirements for future complex applications. Applications require customer acceptance and satisfaction at acceptable cost. Reliability must be guaranteed when using systems in new and critical environments. In iRel40, 79 partners from 14 countries collaborate in 6 technical work packages along the value chain. WP1 focuses on specifications and requirements. WP2 and WP3 focus on modelling, simulation, materials and interfaces based on test vehicles. WP4 applies the test vehicle knowledge to industrial pilots related to production. WP5 applies the knowledge to testing. WP6 focuses on application use cases applying the industrial pilots. We assess and validate the iRel40 results. Reliable electronic components and systems are developed faster and new processes are transferred to production with higher speed. Crucial insight gained by Physics of Failure and AI methods will push overall quality levels and reliability. iRel40 results will strengthen production along the value chain and support sustainable success of Electronic Components and Systems investment in Europe. By collaboration between academy, industry and knowledge institutes on this challenging topic of reliability, the project secures more than 25.000 jobs in the 25 participating production and testing sites in Europe. The project supports new applications and reliable chips push applications in energy efficiency, e-mobility, autonomous driving and IoT. This unique project brings, for the first time ever, world-leading reliability experts and European manufacturing expertise together to generate a sustainable pan-European reliability community.

The EU requires also electronics industry to achieve the ambitious goals of the EU Green Deal, Circular Economy Action Plan and Industrial Strategy for reduction of energy and material consumption, and utilization of circular value chains. Sustronics project is targeting to improve capabilities of European electronics industry to meet these goals and develop new business opportunities from sustainable and greener electronics combined with increase in productivity and new functionalities. The current electronic industry poses significant environmental impacts, such as increasing amount of e-waste, great demand for critical raw materials, and high energy consumption during manufacturing. Electronics industry can specifically decrease its environmental burden by shifting from fossil-based materials to bio-based materials, decreasing use of metals, utilizing additive manufacturing processes, and developing miniaturized and integrated components, but also in broader scope by utilizing efficient circular economy business models that enable reuse, recycle and repair of critical materials and components. Sustronics main goal is to support renewal of European electronics industry towards circular economy, eco-design, bio-based materials, and material- and energy-efficient manufacturing processes. Thereby, Sustronics will re-design electronics products into circular, compostable and reusable products, and demonstrate that there are business opportunities in sustainable electronics. Quantification of environmental impact, definition of business models, involvement of external stakeholders, and means to guarantee compatibility with policies and standards will guide the project implementation. The pilots will focus on healthcare, diagnostics, and industrial sectors, including topics such as medical and personal health devices, single-use and wearable diagnostics, sustainable lighting solutions and embedded electronics for automotive.

Photonics technologies have become a key enabler in the realization of modern medical devices with applications ranging from diagnostics to surgical tools and therapeutics. Characteristic nature of both photonics and application fields is high diversity. Consequently, the more widespread use of photonics technologies in scattered ecosystems presents major challenges for both end-user companies and manufacturers. In conjunction with highly regulated validation and production, the timespan from the concept phase to product launch takes years. Addressing these challenges, MedPhab will serve as Europe’s first Pilot Line dedicated to manufacturing, testing, validation and up-scaling of new photonics technologies for medical diagnostics enabling accelerated product launch with reduced R&D costs. MedPhab will bring the high-quality infrastructure and extensive know-how within easy reach of the SME’s and other European Industry. Globally unique feature of MedPhab is its operation in medical domain setting requirements to meet regulations. The competitive differentiation is the seamless operation between ISO13485 certified companies and RTOs when single-entry point can serve SMEs operating at different TRLs. Professional customer interface will be operated by staff with extensive experience in the field medical devices. The technology readiness and MedPhab operation process will be validated by: 1) Use Case Validation program, upscaling and demonstrating performance of 5 innovative medical diagnostics products; 2) Demo Case Open Calls program enabling early adoption of the technologies by external user, demonstrating the pilot line services and validating the open access business model.